BCAB- Bioatla, Inc.

Name: Bioatla, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Bioatla, Inc. (BCAB) has 10 insiders with recent SEC Form 4 filings, including 8 buys and 41 sells. BCAB is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Short Jay M Phd	2.66M	$11.57M	-
Other	Sievers Eric	598.7K	$2.60M	-
CFO	Vasquez Christian	530.2K	$2.31M	-
CFO	Waldron Richard A	343.4K	$1.49M	-
Dir	Smith Scott Andrew	321.6K	$1.40M	-

Activity

Buys and sells only

Transactions

10 filings · page 2

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Sep 13, 2022	McBrinn Sylvia	Director	Buy	3,000	$8.63	$25,900.00	+150.0%	+11.5%	-75.3%
Aug 12, 2022	Short Jay M Phd87	Chief Executive Officer	Buy	26,350	$7.84	$206,599.81	+1.9%	+16.5%	-61.8%
Jun 22, 2022	Short Jay M Phd87	Chief Executive Officer	Buy	69,390	$2.86	$198,336.18	+2.6%	+185.4%	+26.5%
Jun 9, 2022	Vasquez Christian85	See Remarks	Buy	50,000	$3.02	$150,914.13	+39.1%	+183.5%	+20.5%
Dec 2, 2021	Short Jay M Phd87	Chief Executive Officer	Sell	47,622	$23.48	$1,118,045.94	-0.4%	-71.3%	-54.2%
Dec 2, 2021	Waldron Richard A85	Chief Financial Officer	Sell	14,190	$23.48	$333,147.62	-1.3%	-71.3%	-54.2%
Dec 2, 2021	Vasquez Christian85	See Remarks	Sell	1,979	$23.48	$46,462.15	-0.9%	-71.3%	-54.2%
Dec 2, 2021	Smith Scott Andrew92	President	Sell	4,090	$22.27	$91,099.33	-0.1%	-71.3%	-54.2%
Dec 2, 2021	Sievers Eric91	Chief Medical Officer	Sell	1,124	$22.27	$25,034.59	-0.2%	-71.3%	-54.2%
Nov 29, 2021	Waldron Richard A85	Chief Financial Officer	Sell	4,599	$23.89	$109,870.11	-3.0%	-72.8%	-56.3%

← PrevPage 2Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC